These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8054580)

  • 1. [Stimulation of oxygen metabolism in human blood phagocytes as affected by tuftsin-like peptides derived from the C-reactive protein molecule].
    Polevshchikov AV; Nazarov PG
    Biull Eksp Biol Med; 1993 Jan; 115(1):55-6. PubMed ID: 8054580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuftsin-like peptides from a C-reactive protein molecule as regulators of lymphocyte proliferation].
    Polevshchikov AV; Nazarov PG
    Vopr Med Khim; 1994; 40(1):4-7. PubMed ID: 8122411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analgesic activity of some tuftsin- and tuftsin inhibitor-like fragments of the viral coat proteins.
    Obuchowicz E; Słoń JJ; Klin M; Madej A; Siemion IZ; Herman ZS
    Pol J Pharmacol; 1993; 45(3):269-79. PubMed ID: 8220660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cell attachment peptide from human C-reactive protein.
    Fernandez MC; Mullenix MC; Christner RB; Mortensen RF
    J Cell Biochem; 1992 Sep; 50(1):83-92. PubMed ID: 1429876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tuftsin and its partial sequences on the arterial blood pressure in guinea-pigs.
    Paradowski A; Dynowski Z; Kubik A; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):147-52. PubMed ID: 1804045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
    Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptides from C-reactive protein containing tuftsin-related sequences.
    Buchta R; Fridkin M; Pontet M; Romeo D
    Peptides; 1986; 7(6):961-8. PubMed ID: 3031632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competition between tuftsin and HIV-1, HIV-2 envelope protein sequences.
    Siemion IZ; Słoń J; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):469-78. PubMed ID: 1841544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evidence on the possible interleukin-1 alpha tuftsin competition.
    Siemion IZ; Słoń J; Spiegel K; Wieczorek Z
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):605-11. PubMed ID: 1841557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further investigations on the antinociceptive activity of tuftsin analogs.
    Nawrocka-Bolewska E; Kubik A; Szewczuk Z; Siemion IZ; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1991; 43(4):281-8. PubMed ID: 1811220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, conformation, and immunoreactivity of new carrier molecules based on repeated tuftsin-like sequence.
    Mezö G; Kalászi A; Reményi J; Majer Z; Hilbert A; Láng O; Köhidai L; Barna K; Gaál D; Hudecz F
    Biopolymers; 2004 Apr; 73(6):645-56. PubMed ID: 15048768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of tuftsin partial sequences on histamine level in guinea pig and rat tissues.
    Paradowski A; Rózga M; Wronowska G; Nawrocka-Bolewska E; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1992; 40(3-4):207-12. PubMed ID: 1300985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein.
    Zouki C; Beauchamp M; Baron C; Filep JG
    J Clin Invest; 1997 Aug; 100(3):522-9. PubMed ID: 9239398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intraperitoneal tuftsin administration on histamine concentration in tissues of guinea-pigs.
    Paradowski A; Rózga M; Nawrocka E; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):153-7. PubMed ID: 1804046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of tuftsin-like synthetic peptides derived from C-reactive protein (CRP) on platelet behaviour.
    Fiedel BA
    Immunology; 1988 Jul; 64(3):487-93. PubMed ID: 3044982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity.
    Robey FA; Ohura K; Futaki S; Fujii N; Yajima H; Goldman N; Jones KD; Wahl S
    J Biol Chem; 1987 May; 262(15):7053-7. PubMed ID: 3034878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regulation of oxygen metabolism in human blood leukocytes by C-reactive protein].
    Polevshchikov AV; Kiseleva EP; Berestovaia LK; Nazarov PG
    Fiziol Cheloveka; 1995; 21(2):122-8. PubMed ID: 7628659
    [No Abstract]   [Full Text] [Related]  

  • 18. Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide.
    Li JJ; Chen XJ
    Coron Artery Dis; 2003 Jun; 14(4):329-34. PubMed ID: 12826933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glyco-tuftsin derivatives modulate interleukin-1 and tumor necrosis factor production.
    Rocchi R; Biondi L; Filira F; Tzehoval E; Dagan S; Fridkin M
    Int J Pept Protein Res; 1991 Mar; 37(3):161-6. PubMed ID: 1869367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and functional studies of tuftsin analogs containing isopeptide bond.
    Mezö G; Szekerke M; Sármay G; Gergely J
    Peptides; 1990; 11(3):405-15. PubMed ID: 2381868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.